Financial Advisors Network, Inc. Gilead Sciences, Inc. Transaction History

Financial Advisors Network, Inc.

$496 Million
Q4 2023

A detailed history of Financial Advisors Network, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Financial Advisors Network, Inc. holds 157,969 shares of GILD stock, worth $14.7 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares

157,969

Previous 157,945 0.02%

Holding current value

$14.7 Million

Previous $11.8 Million 8.12%

% of portfolio

2.58%

Previous 2.66%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $1,758 - $1,994	24 Added 0.02%	157,969 $12.8 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $177,160 - $193,285	2,396 Added 1.54%	157,945 $11.8 Million
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $62 - $89	1 Added 0.0%	155,549 $13.4 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $722,957 - $905,943	-12,482 Reduced 7.43%	155,548 $9.25 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $63,452 - $72,019	-978 Reduced 0.58%	168,030 $12.2 Million
Q3 2021 Dec 27, 2021	SELL	$67.69 - $73.03 $11,710 - $12,634	-173 Reduced 0.1%	169,008 $11.4 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $500,207 - $546,547	-7,881 Reduced 4.45%	169,181 $11.7 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $595,740 - $679,739	9,929 Added 5.94%	177,062 $11.4 Million
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $8,894 - $10,134	157 Added 0.09%	167,133 $9.74 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $6,955 - $8,744	-112 Reduced 0.07%	166,976 $10.6 Million
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $84,565 - $98,196	-1,169 Reduced 0.69%	167,088 $12.9 Million
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $45,156 - $57,838	721 Added 0.43%	168,257 $12.6 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $897,063 - $986,741	14,558 Added 9.52%	167,536 $10.9 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $866 - $971	-14 Reduced 0.01%	152,978 $9.77 Million
Q1 2019 Jun 04, 2019	SELL	$62.53 - $70.05 $117,806 - $131,974	-1,884 Reduced 1.22%	152,992 $9.52 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $596,863 - $778,861	9,859 Added 6.8%	154,876 $9.69 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $1.15 Million - $1.34 Million	17,687 Added 13.89%	145,017 $10.3 Million
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $8.62 Million - $10.1 Million	121,161 Added 1964.03%	127,330 $9.12 Million
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $444,846 - $527,264	6,169	6,169 $500,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

993M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisors Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisors Network, Inc. with notifications on news.

Account

Financial Advisors Network, Inc. Gilead Sciences, Inc. Transaction History